Literature DB >> 17395557

Eosinophilic esophagitis is a component of the anticonvulsant hypersensitivity syndrome: description of two cases.

C Balatsinou1, A Milano, M P Caldarella, F Laterza, S D Pierdomenico, F Cuccurullo, M Neri.   

Abstract

Anticonvulsant hypersensitivity syndrome is a rare syndrome caused by a specific, severe unusual reaction to antiepileptic agents; anticonvulsant hypersensitivity syndrome develops 1 week to 3 months after the introduction of the drug and most frequently consists of a multisystemic and multiorgan involvement. Drug withdrawal usually leads to rapid improvement of symptoms. Up to now no oesophageal damage has been described. We present two cases of carbamazepine hypersensitivity syndrome with concomitant development of eosinophilic oesophagitis that resolved after drug withdrawal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395557     DOI: 10.1016/j.dld.2007.01.017

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  6 in total

Review 1.  Biology and treatment of eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

Review 2.  Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review.

Authors:  Ivan Gentile; Maria Talamo; Guglielmo Borgia
Journal:  BMC Infect Dis       Date:  2010-03-06       Impact factor: 3.090

Review 3.  Eosinophilic esophagitis: New insights in pathogenesis and therapy.

Authors:  Michele Pier Luca Guarino; Michele Cicala; Jose Behar
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 4.  Basic pathogenesis of eosinophilic esophagitis.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Gastrointest Endosc Clin N Am       Date:  2008-01

Review 5.  Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.

Authors:  Abdelbaset A Elzagallaai; Sandra R Knowles; Michael J Rieder; John R Bend; Neil H Shear; Gideon Koren
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

6.  Esophageal eosinophilia in pediatric patients with cerebral palsy.

Authors:  Ana Carolina Ramos de Nápolis; Flavia Araujo Alves; Erica Rodrigues Mariano de Almeida Rezende; Gesmar Rodrigues Silva Segundo
Journal:  Einstein (Sao Paulo)       Date:  2015 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.